The glass is either half full or half empty, but either way there is the same amount of water in the glass, unless, of course, you are drinking Calmare Kool-Aid.
Hopefully, the double-blind studies demonstrate results that might help, but only if the results get publicized beyond this board (I have doubts about any posting on the Calmare board making an impact).
Part of the difficulty is that, aside from the overall power of big pharms, it is far easier to prescribe a pill and dosage that requires only popping that pill into your mouth several times a day. The Calmare device requires training in the use of the device and adjusting it for each patient, having the patient travel to a selected site that may not even be in his/her city or state with the associated travel and other costs, and, of course, not knowing(for many) how well it might work.
I have recommended Calmare for someone with CRPS and touted the apparent efficacy of the treatment, but they have yet to act, in part because of costs and in part because of access to the treatment and little understanding and knowledge of Calmare and how it works. As long as Calmare continues to occupy a tiny niche that few know about, hear about, or even believe in, it will remain in this rut. The share price seems to reflect this situation and continued dilution does not help.
Whether a meteoric rise in share price would gain the needed attention or whether the needed attention might cause a meteoric rise, may not matter. right now, however, we have neither. You consider me negative whereas you want to be considered positive. Should I assume that over the many years you have held this stock you have only accumulated shares and never sold?
